359 related articles for article (PubMed ID: 9935078)
1. Synthesis and radiopharmacology of O-(2-[18F]fluoroethyl)-L-tyrosine for tumor imaging.
Wester HJ; Herz M; Weber W; Heiss P; Senekowitsch-Schmidtke R; Schwaiger M; Stöcklin G
J Nucl Med; 1999 Jan; 40(1):205-12. PubMed ID: 9935078
[TBL] [Abstract][Full Text] [Related]
2. Investigation of transport mechanism and uptake kinetics of O-(2-[18F]fluoroethyl)-L-tyrosine in vitro and in vivo.
Heiss P; Mayer S; Herz M; Wester HJ; Schwaiger M; Senekowitsch-Schmidtke R
J Nucl Med; 1999 Aug; 40(8):1367-73. PubMed ID: 10450690
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of F-18-labeled amino acid derivatives and [18F]FDG as PET probes in a brain tumor-bearing animal model.
Wang HE; Wu SY; Chang CW; Liu RS; Hwang LC; Lee TW; Chen JC; Hwang JJ
Nucl Med Biol; 2005 May; 32(4):367-75. PubMed ID: 15878506
[TBL] [Abstract][Full Text] [Related]
4. [Synthesis and radiopharmacology of S-(2-18F-fluoroethyl)-L-methionine for tumor imaging].
Tang GH; Wang MF; Tang XL; Luo L; Gan MQ
Yao Xue Xue Bao; 2003 Dec; 38(12):915-8. PubMed ID: 15040084
[TBL] [Abstract][Full Text] [Related]
5. [Synthesis and preliminary studies of O-(2-[18F] fluoroethyl)-L-tyrosine as a positron emission tomography imaging agent].
Dang YH; Wang SZ; Cheng X; Zhou Q
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Aug; 24(4):370-2. PubMed ID: 12905655
[TBL] [Abstract][Full Text] [Related]
6. Preferred transport of O-(2-[18F]fluoroethyl)-D-tyrosine (D-FET) into the porcine brain.
Makrides V; Bauer R; Weber W; Wester HJ; Fischer S; Hinz R; Huggel K; Opfermann T; Herzau M; Ganapathy V; Verrey F; Brust P
Brain Res; 2007 May; 1147():25-33. PubMed ID: 17343835
[TBL] [Abstract][Full Text] [Related]
7. Biodistribution studies on L-3-[fluorine-18]fluoro-alpha-methyl tyrosine: a potential tumor-detecting agent.
Inoue T; Tomiyoshi K; Higuichi T; Ahmed K; Sarwar M; Aoyagi K; Amano S; Alyafei S; Zhang H; Endo K
J Nucl Med; 1998 Apr; 39(4):663-7. PubMed ID: 9544678
[TBL] [Abstract][Full Text] [Related]
8. Analysis of 18F-FET PET for grading of recurrent gliomas: is evaluation of uptake kinetics superior to standard methods?
Pöpperl G; Kreth FW; Herms J; Koch W; Mehrkens JH; Gildehaus FJ; Kretzschmar HA; Tonn JC; Tatsch K
J Nucl Med; 2006 Mar; 47(3):393-403. PubMed ID: 16513607
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of O-(3-[18F]fluoropropyl)-L-tyrosine as an oncologic PET tracer.
Tang G; Wang M; Tang X; Luo L; Gan M
Nucl Med Biol; 2003 Oct; 30(7):733-9. PubMed ID: 14499331
[TBL] [Abstract][Full Text] [Related]
10. Treatment-Related Uptake of
Geisler S; Stegmayr C; Niemitz N; Lohmann P; Rapp M; Stoffels G; Willuweit A; Galldiks N; Filss C; Sabel MC; Coenen HH; Shah NJ; Langen KJ
J Nucl Med; 2019 Oct; 60(10):1373-1379. PubMed ID: 30850492
[TBL] [Abstract][Full Text] [Related]
11. Comparison of O-(2-18F-fluoroethyl)-L-tyrosine PET and 3-123I-iodo-alpha-methyl-L-tyrosine SPECT in brain tumors.
Pauleit D; Floeth F; Tellmann L; Hamacher K; Hautzel H; Müller HW; Coenen HH; Langen KJ
J Nucl Med; 2004 Mar; 45(3):374-81. PubMed ID: 15001676
[TBL] [Abstract][Full Text] [Related]
12. Dynamic O-(2-18F-fluoroethyl)-L-tyrosine positron emission tomography differentiates brain metastasis recurrence from radiation injury after radiotherapy.
Ceccon G; Lohmann P; Stoffels G; Judov N; Filss CP; Rapp M; Bauer E; Hamisch C; Ruge MI; Kocher M; Kuchelmeister K; Sellhaus B; Sabel M; Fink GR; Shah NJ; Langen KJ; Galldiks N
Neuro Oncol; 2017 Feb; 19(2):281-288. PubMed ID: 27471107
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of D-isomers of O-11C-methyl tyrosine and O-18F-fluoromethyl tyrosine as tumor-imaging agents in tumor-bearing mice: comparison with L- and D-11C-methionine.
Tsukada H; Sato K; Fukumoto D; Nishiyama S; Harada N; Kakiuchi T
J Nucl Med; 2006 Apr; 47(4):679-88. PubMed ID: 16595503
[TBL] [Abstract][Full Text] [Related]
14. O-(2-[18F]fluoroethyl)-L-tyrosine (18F-FET) uptake in mouse thymoma cells, and its biodistribution in mice and human volunteers.
Abe K; Hayashi K; Sasaki M; Koga H; Kaneko K; Sawamoto H; Himuro K; Honda H
Acta Radiol; 2006 Dec; 47(10):1042-8. PubMed ID: 17135006
[TBL] [Abstract][Full Text] [Related]
15. 18F-AFETP, 18F-FET, and 18F-FDG imaging of mouse DBT gliomas.
Sai KK; Huang C; Yuan L; Zhou D; Piwnica-Worms D; Garbow JR; Engelbach JA; Mach RH; Rich KM; McConathy J
J Nucl Med; 2013 Jul; 54(7):1120-6. PubMed ID: 23650628
[TBL] [Abstract][Full Text] [Related]
16. O-(2-[(18)F]Fluoroethyl)- L-tyrosine (FET): a tracer for differentiation of tumour from inflammation in murine lymph nodes.
Rau FC; Weber WA; Wester HJ; Herz M; Becker I; Krüger A; Schwaiger M; Senekowitsch-Schmidtke R
Eur J Nucl Med Mol Imaging; 2002 Aug; 29(8):1039-46. PubMed ID: 12173018
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and evaluation of ¹⁸F labeled FET prodrugs for tumor imaging.
Wang L; Lieberman BP; Ploessl K; Kung HF
Nucl Med Biol; 2014 Jan; 41(1):58-67. PubMed ID: 24183614
[TBL] [Abstract][Full Text] [Related]
18. Uptake of 18F-fluorocholine, 18F-fluoroethyl-L-tyrosine, and 18F-FDG in acute cerebral radiation injury in the rat: implications for separation of radiation necrosis from tumor recurrence.
Spaeth N; Wyss MT; Weber B; Scheidegger S; Lutz A; Verwey J; Radovanovic I; Pahnke J; Wild D; Westera G; Weishaupt D; Hermann DM; Kaser-Hotz B; Aguzzi A; Buck A
J Nucl Med; 2004 Nov; 45(11):1931-8. PubMed ID: 15534065
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of D-isomers of O-18F-fluoromethyl, O-18F-fluoroethyl and O-18F-fluoropropyl tyrosine as tumour imaging agents in mice.
Tsukada H; Sato K; Fukumoto D; Kakiuchi T
Eur J Nucl Med Mol Imaging; 2006 Sep; 33(9):1017-24. PubMed ID: 16699766
[TBL] [Abstract][Full Text] [Related]
20. Role of O-(2-(18)F-fluoroethyl)-L-tyrosine PET for differentiation of local recurrent brain metastasis from radiation necrosis.
Galldiks N; Stoffels G; Filss CP; Piroth MD; Sabel M; Ruge MI; Herzog H; Shah NJ; Fink GR; Coenen HH; Langen KJ
J Nucl Med; 2012 Sep; 53(9):1367-74. PubMed ID: 22872742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
